Building Lifelong Athletes

BLA 152: The LDL Controversy (and the cost of being wrong)

Building Lifelong Athletes

Show Notes

Is LDL cholesterol the villain it's made out to be? In this episode, I dive deep into the fierce online debate surrounding LDL and heart disease. I'll break down the arguments from both skeptics and the medical consensus, examine the evidence from genetics to clinical trials, and discuss the real-world stakes of this decision. Let's navigate the noise together and figure out what truly matters for your long-term health.

Stop stressing over every health detail & start living! My FREE 'Necessary Nine' PDF cuts through the noise, giving you the essential things you need for a healthy life.

➡️ Download Here: https://www.jrennickemd.com/necessaryninepdf

CHAPTERS: 00:00 - The Great LDL Debate 01:27 - Acknowledging the Importance of Scientific Skepticism 02:05 - The High Stakes of the Cholesterol Conversation 04:12 - Deconstructing the Arguments of LDL Skeptics 05:31 - Correlation vs. Causation: Is There a Double Standard? 07:54 - Statin Conspiracies and Statistical Framing 09:37 - Social Media's Influence on the LDL Debate 10:34 - The Counter-Argument: A Mountain of Evidence for LDL's Role 11:58 - Evidence Deep Dive: Genetic Studies 12:53 - Evidence Deep Dive: Randomized Controlled Trials 14:30 - The Quantifiable Cost of Being Wrong 16:51 - How to Navigate the Noise and Evaluate Health Information 19:09 - Thought Experiment: What's More Likely? 20:25 - My Personal Journey and Why "It's Not LDL, It's..." is an Incomplete Picture 22:40 - Merging Modern Medicine with Healthy Lifestyles 24:39 - My Goal: To Be a Pebble in Your Shoe 26:02 - Final Thoughts & Working With Your Doctor

REFERENCES:

https://www.lipid.org/lipid-spin/summer-2022/lipid-hypothesis

https://www.nhlbi.nih.gov/health/atherosclerosis

https://pmc.ncbi.nlm.nih.gov/articles/PMC8954705/

https://pmc.ncbi.nlm.nih.gov/articles/PMC3116370/

https://www.tandfonline.com/doi/full/10.1080/17512433.2018.1519391

https://www.tandfonline.com/doi/abs/10.1080/17512433.2018.1519391?fbclid=IwAR0UnKDCNW1c5raOmTHIuPvSRAkXnKwR_NIvplbgQ22jQ8VurUJmae_pqH8&

Disclaimer

This podcast is for entertainment, education, and informational purposes only. The topics discussed should not solely be used to diagnose, treat , or prevent any condition. The information presented here was created with an evidence based approach, but you please keep in mind that science is always changing and at the time of listening to this there may some new data that makes this information incomplete or inaccurate. Always seek the advice of your personal physician or qualified health care provider for questions regarding any medical condition.

More from Building Lifelong Athletes

Oct 20, 2026

In this episode, I try to cut through the noise of the cholesterol debate and walk through 150 years of vascular science. From ancient mummies to modern genetics, we examine how lipidology reached its consensus, the response-to-retention hypothesis, why ApoB particle count matters more than LDL cholesterol mass, and what landmark clinical trials reveal about cardiovascular risk.

Oct 13, 2026

Was Ancel Keys a visionary pioneer of preventive cardiology or the villain who triggered our metabolic health crisis? In this episode, I pull back the curtain on the real science, the controversial 1953 graph, hidden trial data, and sugar industry influence. We explore where Keys was decades ahead of his time, where his model failed, and what his legacy teaches us about navigating scientific dogma in clinical practice today.

Oct 6, 2026

In this episode, I break down the underlying science of cholesterol, lipoproteins, and heart disease. We'll cut through the online noise and examine how cholesterol actually moves through your bloodstream, why particle count (ApoB) matters more than total cholesterol weight, how statins and other medications work at the cellular level, and how plaque forms in atherosclerosis. Everything you need to understand lipidology 101.

May 19, 2026

Welcome back to the trenches! In our final breakdown of the 2026 ACC/AHA lipid guidelines, we are unpacking the pharmacology toolbox. From statins and ezetimibe to PCSK9 inhibitors and the nuances of side effects like SAMS, I want to give you the practical, evidence-informed strategies we need for our patients. We are all just trying to navigate this together.

See all episodes →